Hatzis G, Ziakas P, Kavantzas N, Triantafyllou A, Sigalas P, Andreadou I, Ioannidis K, Chatzis S, Filis K, Papalampros A, Sigala F. Melatonin attenuates high fat diet-induced fatty liver disease in rats. World J Hepatol 2013; 5(4): 160-169 [PMID: 23671720 DOI: 10.4254/wjh.v5.i4.160]
Corresponding Author of This Article
Dr. Gregorios Hatzis, Associate Professor of Pathophysiology, Department of Pathophysiology, Athens University School of Medicine, 75 Mikras Asias, 11527 Athens, Greece. grhatzis@med.uoa.gr
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Original Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 4 Ordinal logistic regression analysis of melatonin effect in rats on high fat diet
n = 48
OR (95%CI)
P value
Melatonin (per 1 mg/kg increase)
0.69 (0.59-0.83)
< 0.001
Duration (8 wk vs 4 wk)
0.65 (0.20-2.10)
0.47
Table 5 Effect of melatonin on laboratory indices
Melatonin (5 mg/kg)
P value
Melatonin (10 mg/kg)
P value
Lipidemic profile
TC (mg/dL)
-10.7
0.45
-2.2
0.87
LDL (mg/dL)
-6.3
0.60
-3.9
0.74
HDL (mg/dL)
-5.3
0.10
1.9
0.52
TG (mg/dL)
6.7
0.71
-5.2
0.76
Hepatic function
AST (U/L)
-170
0.01
-224
0.001
ALT (U/L)
-62.9
0.01
-93.4
< 0.001
Oxidative profile
MDA
-12.7
< 0.001
-12.2
< 0.001
GSH
20.1
0.004
29.2
< 0.001
Citation: Hatzis G, Ziakas P, Kavantzas N, Triantafyllou A, Sigalas P, Andreadou I, Ioannidis K, Chatzis S, Filis K, Papalampros A, Sigala F. Melatonin attenuates high fat diet-induced fatty liver disease in rats. World J Hepatol 2013; 5(4): 160-169